{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:17:22Z","timestamp":1770437842151,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T00:00:00Z","timestamp":1324252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T00:00:00Z","timestamp":1324252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,10,25]]},"DOI":"10.1038\/onc.2011.591","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T11:57:32Z","timestamp":1324295852000},"page":"4588-4598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens"],"prefix":"10.1038","volume":"31","author":[{"given":"D A","family":"Dart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G N","family":"Brooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sita-Lumsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C L","family":"Bevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,19]]},"reference":[{"key":"BFonc2011591_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581\u2013592.","journal-title":"Ann Oncol"},{"key":"BFonc2011591_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0083-6729(08)60937-1","volume":"55","author":"JM Kokontis","year":"1999","unstructured":"Kokontis JM, Liao S . Molecular action of androgen in the normal and neoplastic prostate. Vitam Horm 1999; 55: 219\u2013307.","journal-title":"Vitam Horm"},{"key":"BFonc2011591_CR3","first-page":"407","volume":"26","author":"G Jenster","year":"1999","unstructured":"Jenster G . The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 1999; 26: 407\u2013421.","journal-title":"Semin Oncol"},{"key":"BFonc2011591_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.bi.63.070194.002315","volume":"63","author":"M-J Tsai","year":"1994","unstructured":"Tsai M-J, O\u2019Malley B . Molecular mechanisms of action of steroid\/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451\u2013486.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2011591_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/76194","volume":"6","author":"AO Brinkmann","year":"2000","unstructured":"Brinkmann AO, Trapman J . Prostate cancer schemes for androgen escape. Nat Med 2000; 6: 628\u2013629.","journal-title":"Nat Med"},{"key":"BFonc2011591_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nm0104-26","volume":"10","author":"JT Isaacs","year":"2004","unstructured":"Isaacs JT, Isaacs WB . Androgen receptor outwits prostate cancer drugs. Nat Med 2004; 10: 26\u201327.","journal-title":"Nat Med"},{"key":"BFonc2011591_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/138920209787581307","volume":"10","author":"GN Brooke","year":"2009","unstructured":"Brooke GN, Bevan CL . The role of androgen receptor mutations in prostate cancer progression. Curr Genomics 2009; 10: 18\u201325.","journal-title":"Curr Genomics"},{"key":"BFonc2011591_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM . The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889\u2013895.","journal-title":"Science"},{"key":"BFonc2011591_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.bi.63.070194.002315","volume":"63","author":"MJ Tsai","year":"1994","unstructured":"Tsai MJ, O\u2019Malley BW . Molecular mechanisms of action of steroid\/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451\u2013486.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2011591_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0303-7207(01)00466-X","volume":"179","author":"AO Brinkmann","year":"2001","unstructured":"Brinkmann AO . Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001; 179: 105\u2013109.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2011591_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/76194","volume":"6","author":"AO Brinkmann","year":"2000","unstructured":"Brinkmann AO, Trapman J . Prostate cancer schemes for androgen escape. Nat Med 2000; 6: 628\u2013629.","journal-title":"Nat Med"},{"key":"BFonc2011591_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nm0104-26","volume":"10","author":"JT Isaacs","year":"2004","unstructured":"Isaacs JT, Isaacs WB . Androgen receptor outwits prostate cancer drugs. Nat Med 2004; 10: 26\u201327.","journal-title":"Nat Med"},{"key":"BFonc2011591_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/sj.onc.1209967","volume":"26","author":"SC Gamble","year":"2007","unstructured":"Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM et al. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene 2007; 26: 1757\u20131768.","journal-title":"Oncogene"},{"key":"BFonc2011591_CR14","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1038\/sj.onc.1207444","volume":"23","author":"SC Gamble","year":"2004","unstructured":"Gamble SC, Odontiadis M, Waxman J, Westbrook JA, Dunn MJ, Wait R et al. Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene 2004; 23: 2996\u20133004.","journal-title":"Oncogene"},{"key":"BFonc2011591_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00018-002-8411-0","volume":"59","author":"LG Nijtmans","year":"2002","unstructured":"Nijtmans LG, Artal SM, Grivell LA, Coates PJ . The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci 2002; 59: 143\u2013155.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2011591_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1283","volume":"7","author":"K Rajalingam","year":"2005","unstructured":"Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 2005; 7: 837\u2013843.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011591_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0960-9822(06)00261-2","volume":"7","author":"PJ Coates","year":"1997","unstructured":"Coates PJ, Jamieson DJ, Smart K, Prescott AR, Hall PA . The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 1997; 7: 607\u2013610.","journal-title":"Curr Biol"},{"key":"BFonc2011591_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0531-5565(94)00069-7","volume":"30","author":"JK McClung","year":"1995","unstructured":"McClung JK, Jupe ER, Liu XT, Dell\u2019Orco RT . Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol 1995; 30: 99\u2013124.","journal-title":"Exp Gerontol"},{"key":"BFonc2011591_CR19","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/sj.onc.1210806","volume":"27","author":"D Choi","year":"2008","unstructured":"Choi D, Lee SJ, Hong S, Kim IH, Kang S . Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways. Oncogene 2008; 27: 1716\u20131725.","journal-title":"Oncogene"},{"key":"BFonc2011591_CR20","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1038\/sj.onc.1205944","volume":"21","author":"S Wang","year":"2002","unstructured":"Wang S, Fusaro G, Padmanabhan J, Chellappan SP . Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002; 21: 8388\u20138396.","journal-title":"Oncogene"},{"key":"BFonc2011591_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1210\/me.2007-0400","volume":"22","author":"B He","year":"2008","unstructured":"He B, Feng Q, Mukherjee A, Lonard DM, DeMayo FJ, Katzenellenbogen BS et al. A repressive role for prohibitin in estrogen signaling. Mol Endocrinol 2008; 22: 344\u2013360.","journal-title":"Mol Endocrinol"},{"key":"BFonc2011591_CR22","doi-asserted-by":"publisher","first-page":"47853","DOI":"10.1074\/jbc.M305171200","volume":"278","author":"G Fusaro","year":"2003","unstructured":"Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S . Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 2003; 278: 47853\u201347861.","journal-title":"J Biol Chem"},{"key":"BFonc2011591_CR23","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/sj.emboj.7600231","volume":"23","author":"S Wang","year":"2004","unstructured":"Wang S, Zhang B, Faller DV . BRG1\/BRM and prohibitin are required for growth suppression by estrogen antagonists. Embo J 2004; 23: 2293\u20132303.","journal-title":"Embo J"},{"key":"BFonc2011591_CR24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/carcin\/bgn117","volume":"29","author":"Y Dai","year":"2008","unstructured":"Dai Y, Ngo D, Jacob J, Forman LW, Faller DV . Prohibitin and the SWI\/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Carcinogenesis 2008; 29: 1725\u20131733.","journal-title":"Carcinogenesis"},{"key":"BFonc2011591_CR25","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1128\/MCB.02142-05","volume":"26","author":"S Rastogi","year":"2006","unstructured":"Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan S . Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol 2006; 26: 4161\u20134171.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011591_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0959-437X(00)00058-7","volume":"10","author":"JC Eissenberg","year":"2000","unstructured":"Eissenberg JC, Elgin SC . The HP1 protein family: getting a grip on chromatin. Curr Opin Genet Dev 2000; 10: 204\u2013210.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2011591_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1677\/ERC-09-0028","volume":"16","author":"DA Dart","year":"2009","unstructured":"Dart DA, Spencer-Dene B, Gamble SC, Waxman J, Bevan CL . Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours. Endocr Relat Cancer 2009; 16: 1157\u20131169.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2011591_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1677\/joe.1.06972","volume":"191","author":"D Pignatelli","year":"2006","unstructured":"Pignatelli D, Xiao F, Gouveia AM, Ferreira JG, Vinson GP . Adrenarche in the rat. J Endocrinol 2006; 191: 301\u2013308.","journal-title":"J Endocrinol"},{"key":"BFonc2011591_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0024-3205(92)90204-3","volume":"50","author":"WM van Weerden","year":"1992","unstructured":"van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schroder FH . Adrenal glands of mouse and rat do not synthesize androgens. Life Sci 1992; 50: 857\u2013861.","journal-title":"Life Sci"},{"key":"BFonc2011591_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1530\/acta.0.0810170","volume":"81","author":"B de la Torre","year":"1976","unstructured":"de la Torre B, Benagiano G, Diczfalusy E . Pathways of testosterone synthesis in decapsulated testes of mice. Acta Endocrinologica 1976; 81: 170\u2013184.","journal-title":"Acta Endocrinologica"},{"key":"BFonc2011591_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0022-4731(89)90392-0","volume":"32","author":"CM Feek","year":"1989","unstructured":"Feek CM, Tuzi NL, Edwards CR . The adrenal gland and progesterone stimulates testicular steroidogenesis in the rat in vivo. J Steroid Biochem 1989; 32: 573\u2013579.","journal-title":"J Steroid Biochem"},{"key":"BFonc2011591_CR32","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1074\/jbc.M805081200","volume":"284","author":"LJ Mullins","year":"2009","unstructured":"Mullins LJ, Peter A, Wrobel N, McNeilly JR, McNeilly AS, Al-Dujaili EA et al. Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. J Biol Chem 2009; 284: 3925\u20133934.","journal-title":"J Biol Chem"},{"key":"BFonc2011591_CR33","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.156.9.3174","volume":"156","author":"W Min","year":"1996","unstructured":"Min W, Pober JS, Johnson DR . Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. J Immunol 1996; 156: 3174\u20133183.","journal-title":"J Immunol"},{"key":"BFonc2011591_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1042\/BJ20060364","volume":"401","author":"B Joshi","year":"2007","unstructured":"Joshi B, Rastogi S, Morris M, Carastro LM, DeCook C, Seto E et al. Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites. Biochem J 2007; 401: 155\u2013166.","journal-title":"Biochem J"},{"key":"BFonc2011591_CR35","doi-asserted-by":"publisher","first-page":"48366","DOI":"10.1074\/jbc.M209074200","volume":"277","author":"Z Kang","year":"2002","unstructured":"Kang Z, Pirskanen A, Janne OA, Palvimo JJ . Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 2002; 277: 48366\u201348371.","journal-title":"J Biol Chem"},{"key":"BFonc2011591_CR36","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1210\/me.2004-0245","volume":"18","author":"Z Kang","year":"2004","unstructured":"Kang Z, Janne OA, Palvimo JJ . Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 2004; 18: 2633\u20132648.","journal-title":"Mol Endocrinol"},{"key":"BFonc2011591_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0092-8674(03)00934-6","volume":"115","author":"R Metivier","year":"2003","unstructured":"Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003; 115: 751\u2013763.","journal-title":"Cell"},{"key":"BFonc2011591_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jcb.22324","volume":"108","author":"SL Shi","year":"2009","unstructured":"Shi SL, Li QF, Liu QR, Xu DH, Tang J, Liang Y et al. Nuclear matrix protein, prohibitin, was down-regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and tanshinone IIA (RCT). J Cell Biochem 2009; 108: 926\u2013934.","journal-title":"J Cell Biochem"},{"key":"BFonc2011591_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jsbmb.2004.04.009","volume":"91","author":"F Chen","year":"2004","unstructured":"Chen F, Knecht K, Leu C, Rutledge SJ, Scafonas A, Gambone C et al. Partial agonist\/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol. J Steroid Biochem Mol Biol 2004; 91: 247\u2013257.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFonc2011591_CR40","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1158\/0008-5472.CAN-04-3679","volume":"65","author":"L Jia","year":"2005","unstructured":"Jia L, Coetzee GA . Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Res 2005; 65: 8003\u20138008.","journal-title":"Cancer Res"},{"key":"BFonc2011591_CR41","first-page":"4552","volume":"63","author":"L Zhang","year":"2003","unstructured":"Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M et al. Interrogating androgen receptor function in recurrent prostate cancer. Cancer Res 2003; 63: 4552\u20134560.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011591","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T22:59:17Z","timestamp":1686524357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,19]]},"references-count":41,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2012,10,25]]}},"alternative-id":["BFonc2011591"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.591","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,19]]},"assertion":[{"value":"2 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}